HIV-2 Infection Clinical Trial
Official title:
Cohorte ANRS CO5 "Cohorte Nationale VIH2"
The HIV2 study is an open cohort of prospective, multicentric, national observation. The main objective is to study HIV-2 infection in adult patients followed in France.
The secondary objectives are : - Describe the epidemiological and clinical characteristics of participants infected with HIV-2, and the immuno-virological characteristics of the infection. - To study the clinical and immunological progression of HIV-2 infection and the prognostic factors of this evolution. - Study the response to antiretroviral treatment (clinical, immuno-virological) and contribute to the identification of the antiretroviral strategies and combinations most suited to the particularities of the infection. - Allow an evaluation of the care practices of participants followed in French hospitals - Provide a bank of clinical-biological data and samples allowing the performance of virological and / or immunological studies on HIV-2 infection. The follow-up of the participants is different according to the therapeutic status of the participants, naive of antiretroviral treatment or already treated with antiretrovirals. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02180438 -
An Open Label Trial of Stribild for Antiretroviral (ARV)-naïve HIV-2 Infected Adults in Dakar, Senegal
|
Phase 4 | |
| Active, not recruiting |
NCT04888754 -
A Prospective Cohort for ex Vivo Cure Studies With Chronic HIV Infected Patients in the Netherlands
|
||
| Terminated |
NCT03394196 -
RESIST-2: 2nd-line ART for HIV-2 Infection
|
N/A | |
| Completed |
NCT01605890 -
Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients
|
Phase 2 | |
| Completed |
NCT02150993 -
First-Line Treatment for HIV-2
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05215704 -
Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIV
|
||
| Completed |
NCT04971343 -
Access HIV Ag/Ab Combo Assay - European Union (EU) Clinical Trial Protocol
|